中国医药 (600056)

China Meheco Group Co., Ltd.

ASH

Tags

SSE 580 IndexCentral State-Owned EnterprisesCSI Central State-Owned Enterprises IndexGeneric DrugsInnovative DrugsPharmaceuticals and HealthcarePharmaceutical CommerceWholesaleHepatitis ConceptMargin Trading and Securities LendingChina Securities Finance and Central Huijin HoldingsHigh Accounts Receivable

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 149587.97
  • Circulating A-Shares(W): 149535.15
  • Earnings Per Share(RMB): 0.3040
  • Net Assets Per Share(RMB): 7.9237
  • Operating Revenue(W RMB): 2589443.51
  • Total Profit(W RMB): 82244.77
  • **Net Profit Attributable to Parent(W RMB) **: 45476.39
  • Net Profit Growth Rate(%): 1.70
  • Weighted Return on Equity(%): 3.7200
  • Operating Cash Flow Per Share(RMB): -0.2090
  • Undistributed Profit Per Share(RMB): 5.2984
  • Capital Reserve Per Share(RMB): 1.2027

2. Main Business

The main business covers:

  • Operating medical devices

3. Company Basic Information

  • Company Name: China Meheco Group Co., Ltd.
  • Listing Date: 1997-05-15
  • Industry: Medicine and Healthcare - Pharmaceutical Business
  • Address: Floor 18-28, Tower B, General Times Center, Building 1, Block 1, Xiying Street, Fengtai District, Beijing
  • Website: https://www.meheco.com
  • Company Profile: The company was exclusively established by the former China National Technical Import & Export Corporation in April 1997, with its net assets converted into 90 million state shares. After the initial public offering on the Shanghai Stock Exchange on April 28, 1997, the total share capital reached 120 million shares. Its 3 million internal employee shares were scheduled to be listed for trading six months after the 27 million public shares started trading on May 15, 1997.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 China General Technology (Group) Holding Co., Ltd. General Legal Person 47742.42 31.93
2 General Tianfang Pharmaceutical Group Co., Ltd. General Legal Person 15087.77 10.09
3 China Aerospace Science and Industry Corporation Limited General Legal Person 14000.00 9.36
4 Central Huijin Asset Management Co., Ltd. Special Legal Person 3051.41 2.04
5 General Technology Group Pharmaceutical Holding Co., Ltd. General Legal Person 2065.14 1.38
6 CSI 500 Exchange Traded Open-End Index Securities Investment Fund Fund 1091.37 0.73
7 Hong Kong Securities Clearing Company Ltd. Northbound Funds 832.04 0.56

5. Concept Sectors

  • Generic Drugs
  • Hepatitis Concept
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • China State-owned Enterprises (Zhong Zi Tou)
  • China Securities Finance & Central Huijin
  • High Accounts Receivable
  • CSI Central SOEs
  • SSE 580

Remarks

  • Data update date: 2025-10-28
  • Data source: Public Market Information